Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A randomized clinical trial published in May 2026 in The Lancet investigated whether semaglutide, a GLP-1 peptide that acts as a GLP-1 receptor agonist and is approved for obesity treatment, was associated with changes in alcohol consumption among adults living with both obesity and alcohol use disorder
The 10mg option is often suitable for smaller research projects, while the 50mg option may be better for larger studies, longer research timelines, or laboratories that need more material on hand
Specifically, it targets genes that control cell death, nerve growth, and brain plasticity
By activating GLP-1 receptors in multiple locations throughout the body, these drugs slow gastric emptying (the rate at which food leaves the stomach), enhance feelings of satiety, and reduce appetite
Overall, the accuracy of subtype 1a or 1b assignment by the GT Plus assay in comparison to either sequencing or LiPA was 140/142 (98.6%)
Meet with our provider in-office or through secure telehealth
US$ 27.90
US$ 25.52
US$ 28.32
US$ 24.02
US$ 1072.50
Sold : Login>>
